VAXART INC.

Lobbying client · California · filed 2025 to 2026

Clinical-stage biotechnology company.

$270,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (68127), not by name.

Firms hired 1

TODD STRATEGY GROUP $270,000 6 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $150,000 4 filings

Issues lobbied 1

Medical/Disease Research/Clinical Labs 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

Health & Human Services, Dept of (HHS) 5

Recent filings 6 total

Q2

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 20, 2026

View → Q1

TODD STRATEGY GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 20, 2026

View → Q4

TODD STRATEGY GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · $50,000 income · posted Jan 20, 2026

View → Q3

TODD STRATEGY GROUP

3rd Quarter (July 1 - Sep 30) 2025 · $50,000 income · posted Oct 12, 2025

View → Q2

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · $50,000 income · posted Jul 30, 2025

View → RR

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.